Lund Arthritis Research Group (LARG)
1 – 10 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
- Contribution to journal › Article
-
Mark
Exploring the Gap Between Clinical Trials and Real-World Practice in Psoriatic Arthritis
(2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2025
-
Mark
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors : a nationwide direct drug-to-drug comparison
- Contribution to journal › Article
-
Mark
Increased prevalence of osteopenia and osteoporosis in systemic sclerosis patients, including in men and young women—a case–control study
- Contribution to journal › Article
-
Mark
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
- Contribution to journal › Article
-
Mark
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis : results from nine European registries
- Contribution to journal › Article
-
Mark
Biological material for biomarker research in spondyloarthritis : mapping the availability in European rheumatology registries
- Contribution to journal › Letter
-
Mark
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden
- Contribution to journal › Article
-
Mark
Prevalence and Predictors of Achieving Sustained Remission in Psoriatic Arthritis : A Swedish Nationwide Registry Study
- Contribution to journal › Article
-
Mark
Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis
- Contribution to journal › Article
